Howell Peyton R

Track

Insider profile

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Howell Peyton R's trades of Tandem Diabetes Care, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
151.99
Quantity 84,218 -3.3%
Value US$4,997,539
Transaction date
Purchase
Price
451.05
Quantity 11,380 -21.5%
Value US$299,901
Transaction date
Purchase
Price
153.85
Quantity 49,708 -3.1%
Value US$265,412
Transaction date
Purchase
Price
75.21
Quantity 400 +25.6%
Value US$30,084
Transaction date
Purchase
Price
74.60
Quantity 500 +46.9%
Value US$37,300
Transaction date
Purchase
Price
74.57
Quantity 17 +1.6%
Value US$1,268
Transaction date
Purchase
Price
75.21
Quantity 100 +10.5%
Value US$7,521
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-19 2023-05-17
B Purchase
84,218 -3.3%
151.99
US$4,997,539 		84,218 -3.3% 151.99 US$4,997,539
2022-05-10 2022-05-06
B Purchase
11,380 -21.5%
451.05
US$299,901 		11,380 -21.5% 451.05 US$299,901
2022-05-10 2022-05-06
B Purchase
49,708 -3.1%
153.85
US$265,412 		49,708 -3.1% 153.85 US$265,412
2022-05-10 2022-05-06
B Purchase
400 +25.6%
75.21
US$30,084 		400 +25.6% 75.21 US$30,084
2022-05-10 2022-05-06
B Purchase
500 +46.9%
74.60
US$37,300 		500 +46.9% 74.60 US$37,300
2022-05-10 2022-05-06
B Purchase
17 +1.6%
74.57
US$1,268 		17 +1.6% 74.57 US$1,268
2022-05-10 2022-05-06
B Purchase
100 +10.5%
75.21
US$7,521 		100 +10.5% 75.21 US$7,521